Nature of Business (Details) |
1 Months Ended | |||||
|---|---|---|---|---|---|---|
|
Apr. 01, 2024
USD ($)
Program
|
Sep. 30, 2024 |
Jun. 30, 2025
USD ($)
Program
|
Dec. 31, 2024
USD ($)
|
Jun. 30, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
|
| Nature of Business | ||||||
| Number of clinical programs (in programs) | Program | 4 | |||||
| Reverse stock split ratio | 0.04 | |||||
| Accumulated deficit | $ 628,579,000 | $ 649,154,000 | ||||
| Cash and cash equivalents | $ 13,081,000 | $ 21,338,000 | $ 16,886,000 | $ 20,821,000 | ||
| Trawsfynydd IPR&D | ||||||
| Nature of Business | ||||||
| Number of programs | Program | 2 | |||||
| Cash and cash equivalents | $ 44,000 |
| X | ||||||||||
- Definition Represents the number of clinical programs. No definition available.
|
| X | ||||||||||
- Definition Number of programs grouped as asset. No definition available.
|
| X | ||||||||||
- Definition Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of accumulated undistributed earnings (deficit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|